<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25553299</article-id>
      <article-id pub-id-type="pmc">4272950</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2015.35.1.152</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
          <subj-group subj-group-type="heading">
            <subject>Diagnostic Hematology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The First Case Report of Composite Bone Marrow Involvement by Simultaneously Developed Peripheral T-Cell Lymphoma, Not Otherwise Specified, and Diffuse Large B-Cell Lymphoma</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Hyun-Ki</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Park</surname>
            <given-names>Chan-Jeoung</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jang</surname>
            <given-names>Seongsoo</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cho</surname>
            <given-names>Young-Uk</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Sang Hyuk</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Choi</surname>
            <given-names>Jene</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Chan-Sik</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huh</surname>
            <given-names>Jooryung</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chung</surname>
            <given-names>Young-Hwa</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Jung-Hee</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Laboratory Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Pathology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.</aff>
      <aff id="A4"><label>4</label>Department of Internal Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Chan-Jeoung Park. Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea. Tel: +82-2-3010-4508, Fax: +82-2-478-0884, <email>cjpark@amc.seoul.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>08</day>
        <month>12</month>
        <year>2014</year>
      </pub-date>
      <volume>35</volume>
      <issue>1</issue>
      <fpage>152</fpage>
      <lpage>154</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>4</month>
          <year>2014</year>
        </date>
        <date date-type="rev-recd">
          <day>23</day>
          <month>6</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>10</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Lymphomas of different histological types can occur at the same anatomical site (composite lymphoma) or at different sites, and can arise simultaneously or sequentially [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>]. Reports of patients in whom histologically distinct lymphomas occur simultaneously at different sites are rare [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>]. Among these rare cases, the simultaneous occurrence of T- and B-cell lymphomas is extremely rare [<xref rid="B5" ref-type="bibr">5</xref>]. To the best of our knowledge, composite involvement of T- and B-cell lymphomas in the bone marrow (BM) have not been reported so far. We report a case of composite BM involvement by T- and B-cell lymphomas.</p>
    <p>A 52-yr-old woman presented with abdominal discomfort. She had a history of hepatitis B-related liver cirrhosis and was taking lamivudine. She had lost 4 kg of weight in the previous 4 months. Laboratory investigation revealed pancytopenia (white blood cells, 1.7&#xD7;10<sup>9</sup>/L [reference range: 4-10&#xD7;10<sup>9</sup>/L]; hemoglobin, 11.0 g/dL [12-16 g/dL]; and platelets, 75&#xD7;10<sup>9</sup>/L [150-350&#xD7;10<sup>9</sup>/L]), elevated levels of liver enzymes (aspartate transaminase, 75 IU/L [0-40 IU/L]; alkaline phosphatase, 129 IU/L [40-120 IU/L]; &#x3B3;-glutamyltransferase, 99 IU/L [8-35 IU/L]), and an increased level of lactate dehydrogenase (315 IU/L [120-250 IU/L]). Dynamic computed tomography revealed an ill-defined, 3-cm lesion in the left lateral segment of the liver and multiple abdominal and mediastinal lymphadenopathies. Esophagogastroduodenoscopy revealed a 3-cm ulcerofungating mass between the antrum and the lower body of the stomach. A liver core needle biopsy identified a peripheral T-cell lymphoma, not otherwise specified, and an endoscopic biopsy of the stomach identified a diffuse large B-cell lymphoma (DLBL). A BM biopsy revealed BM involvement by DLBL with a nodular infiltration pattern, which was corroborated by positive immunohistochemical staining for CD3 and CD20. CD20-positive lymphocytes were present in nodular aggregates. CD3-positive lymphocytes were present in small lymphocytes surrounding CD20-positive lymphocytes suggesting reactive T lymphocytes. A cytogenetic study of BM revealed an apparently normal karyotype. The patient was started on the combination chemotherapy regimen including rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP).</p>
    <p>After 6 cycles of R-CHOP, the liver mass and lymphadenopathies had disappeared. However, a follow-up BM biopsy revealed BM involvement by T-cell lymphoma and DLBL. Immunohistochemical staining showed medium to large sized PAX5-positive lymphocytes with a marked interstitial infiltration pattern (<xref ref-type="fig" rid="F1">Fig. 1A, B</xref>), and the cells were also CD79a-positive. Peritrabecular and interstitial infiltration of small to medium sized CD3-positive lymphocytes was also prominent (<xref ref-type="fig" rid="F1">Fig. 1C, D</xref>). Rearrangements of the T-cell receptor gamma locus (<italic>TRG</italic>) and immunoglobulin heavy locus (<italic>IGH</italic>) were studied in BM (after the 6th cycle of R-CHOP), liver, and stomach (at diagnosis) specimens using the BIOMED-2 multiplex PCR protocol [<xref rid="B6" ref-type="bibr">6</xref>]. A 170-bp monoclonal <italic>TRG</italic> rearrangement was detected in the liver sample (<xref ref-type="fig" rid="F2">Fig. 2A</xref>), while <italic>TRG</italic> in the BM had a larger 160-bp peak with a smaller 170-bp peak (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). <italic>IGH</italic> gene rearrangements were not detected in the stomach sample or in the BM aspirate, and the BM aspirate had a normal karyotype. After the 8th R-CHOP cycle, computed tomography and positron emission tomography findings suggested involvement of multiple lymph nodes (celiac, splenic hilar, and abdominal paraaortic lymph nodes). The patient died of pneumonia 1 yr after diagnosis.</p>
    <p>In our <italic>TRG</italic> rearrangement study, monoclonal <italic>TRG</italic> rearrangements were detected in both liver and BM samples, but the sizes of amplicons were slightly different, that is a finding that may be explained by clonal evolution [<xref rid="B7" ref-type="bibr">7</xref>]. We speculate that there is BM involvement on the basis of a subclone from the hepatic T-cell lymphoma. Moreover, a small peak corresponding to a 170-bp PCR product was observed in a BM sample, which suggests that the same clone present in the liver sample was also present in the BM sample. Monoclonal <italic>IGH</italic> rearrangements were not detected in the stomach or BM sample. As monoclonal <italic>IGH</italic> rearrangements are detected in approximately 80% of DLBL cases using BIOMED-2 multiplex PCR [<xref rid="B8" ref-type="bibr">8</xref>], the fact that rearrangement of <italic>IGH</italic> was not detected in the stomach sample is not unusual.</p>
    <p>T- and B-cell lymphomas simultaneously developed in this patient. Moreover, a follow-up examination suggested BM involvement by both these lymphomas. To our knowledge, this is the first report of a patient with BM involvement by both T- and B-cell lymphomas. Factors contributing to the development of synchronous primary lymphomas have not been investigated, and a case with involvement of the same site by two different lymphomas has not been reported; however, primary composite lymphomas have been reported [<xref rid="B9" ref-type="bibr">9</xref>]. The clinical significance of BM involvement by both T- and B-cell lymphomas is unknown, although the simultaneous development of more than one histological type of lymphoma is associated with a poor prognosis [<xref rid="B1" ref-type="bibr">1</xref>]. The present patient died 1 yr after her diagnosis, suggesting that composite BM involvement may also be associated with a poor prognosis.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tucci</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Motta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ungari</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ruggeri</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Crippa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Borlenghi</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis</article-title>
          <source>Haematologica</source>
          <year>2005</year>
          <volume>90</volume>
          <fpage>348</fpage>
          <lpage>352</lpage>
          <pub-id pub-id-type="pmid">15749667</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Furlan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pietrogrande</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Marino</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Menin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Polato</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vianello</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Sequential development of large B cell lymphoma in a patient with peripheral T-cell lymphoma</article-title>
          <source>Haematologica</source>
          <year>2008</year>
          <volume>93</volume>
          <fpage>e6</fpage>
          <lpage>e8</lpage>
          <pub-id pub-id-type="pmid">18166774</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Terada</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>One patient with double lymphomas: simultaneous gastric MALT lymphoma and ileal diffuse large B-cell lymphoma</article-title>
          <source>Int J Clin Exp Pathol</source>
          <year>2012</year>
          <volume>5</volume>
          <fpage>260</fpage>
          <lpage>263</lpage>
          <pub-id pub-id-type="pmid">22558482</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Jing</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Lindeman</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Ferry</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>One patient, two lymphomas. Simultaneous primary gastric marginal zone lymphoma and primary duodenal follicular lymphoma</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2004</year>
          <volume>128</volume>
          <fpage>1035</fpage>
          <lpage>1038</lpage>
          <pub-id pub-id-type="pmid">15335250</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cotter</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Lister</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>Simultaneous presentation of T- and B-cell malignant lymphoma with bcl-2 gene involvement</article-title>
          <source>Blood</source>
          <year>1989</year>
          <volume>73</volume>
          <fpage>1387</fpage>
          <lpage>1388</lpage>
          <pub-id pub-id-type="pmid">2649177</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Dongen</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Langerak</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Bruggemann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Hummel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lavender</surname>
              <given-names>FL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936</article-title>
          <source>Leukemia</source>
          <year>2003</year>
          <volume>17</volume>
          <fpage>2257</fpage>
          <lpage>2317</lpage>
          <pub-id pub-id-type="pmid">14671650</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Umino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nakagawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Utsunomiya</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tsukasaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Taira</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Katayama</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clonal evolution of adult T-cell leukemia/lymphoma takes place in the lymph nodes</article-title>
          <source>Blood</source>
          <year>2011</year>
          <volume>117</volume>
          <fpage>5473</fpage>
          <lpage>5478</lpage>
          <pub-id pub-id-type="pmid">21447829</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evans</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Pott</surname>
              <given-names>Ch</given-names>
            </name>
            <name>
              <surname>Groenen</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Salles</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Davi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936</article-title>
          <source>Leukemia</source>
          <year>2007</year>
          <volume>21</volume>
          <fpage>207</fpage>
          <lpage>214</lpage>
          <pub-id pub-id-type="pmid">17170731</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>YL</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>JY</given-names>
            </name>
          </person-group>
          <article-title>Composite diffuse large B-cell lymphoma and classical Hodgkin's lymphoma of the stomach: case report and literature review</article-title>
          <source>World J Gastroenterol</source>
          <year>2013</year>
          <volume>19</volume>
          <fpage>6304</fpage>
          <lpage>6309</lpage>
          <pub-id pub-id-type="pmid">24115832</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>Bone marrow biopsy after 6 cycles of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) combination chemotherapy. (A, B) Neoplastic B lymphocytes infiltrating in an interstitial pattern was immunohistochemically analyzed by anti-PAX5 antibody (A, &#xD7;100; B, &#xD7;1,000). (C, D) Neoplastic T lymphocytes infiltrating with a peritrabecular or interstitial pattern was immunohistochemically analyzed by anti-CD3 antibody (C, &#xD7;100; D, &#xD7;1,000).</p>
      </caption>
      <graphic xlink:href="alm-35-152-g001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>T cell receptor gamma locus (<italic>TRG</italic>) rearrangement analyzed by using BIOMED-2 multiplex PCR. Horizontal axis represents amplicon size (base pairs) and vertical axis represents fluorescence intensity. (A) A monoclonal <italic>TRG</italic> rearrangement was detected at 170 bp in the liver sample. (B) Both a larger peak (160 bp) and a smaller peak (170 bp) were observed in the bone marrow aspirate sample by GeneScan analysis of the PCR results.</p>
      </caption>
      <graphic xlink:href="alm-35-152-g002"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
